|
C9ORF40 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.505990E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.113590E-01 |
| Normal-vs-Stage2 |
3.309800E-01 |
| Normal-vs-Stage3 |
4.702400E-01 |
| Normal-vs-Stage4 |
4.535000E-01 |
| Stage1-vs-Stage2 |
9.103400E-01 |
| Stage1-vs-Stage3 |
5.115600E-01 |
| Stage1-vs-Stage4 |
7.372800E-01 |
| Stage2-vs-Stage3 |
7.318000E-01 |
| Stage2-vs-Stage4 |
8.763200E-01 |
| Stage3-vs-Stage4 |
8.687800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.158390E-01 |
| Normal-vs-AfricanAmerican |
5.681600E-01 |
| Normal-vs-Asian |
9.828200E-01 |
| Caucasian-vs-AfricanAmerican |
8.344600E-01 |
| Caucasian-vs-Asian |
2.447800E-01 |
| AfricanAmerican-vs-Asian |
5.523000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.564200E-01 |
| Normal-vs-Female |
9.791900E-02 |
| Male-vs-Female |
2.755600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.264000E-02 |
| Normal-vs-Age(41-60Yrs) |
8.072400E-01 |
| Normal-vs-Age(61-80Yrs) |
5.909500E-02 |
| Normal-vs-Age(81-100Yrs) |
4.364000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.317800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.885800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.657400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.370000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.619600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.543600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.802800E-01 |
| Classical-VS-Follicular |
4.187600E-01 |
| Classical-VS-Other |
5.591400E-01 |
| Classical-VS-Normal |
1.831030E-01 |
| Tall-VS-Follicular |
1.218810E-01 |
| Tall-VS-Other |
2.353800E-01 |
| Tall-VS-Normal |
8.296400E-01 |
| Follicular-VS-Other |
7.955400E-01 |
| Follicular-VS-Normal |
1.077230E-01 |
| Other-VS-Normal |
2.211000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.873600E-02 |
| Normal-vs-N1 |
4.237800E-01 |
| N0-vs-N1 |
3.434600E-01 |
|
|
